Screening Flashcards

1
Q

What is screening

A

Systematic testing to detect disease at a stage when cure/control is possible.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Screening vs Diagnosis

A

Traditional diagnosis involves individuals with symptomatic disease.

Screening involves asymptomatic individuals with low pretest probability of disease.

(Diagnosis almost always happens when patients come in and coplain about symptom. While screening happens when individuals without obvious symptom come voluntarily.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When to screen

A

Ideally, we want to screen population at “Biologic onset” stage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why screening?

A
  1. Early detection of disease precursors/signals and disease susceptibility in individuals who without diagnosed disease.
  2. Control disease development and recurrence, and its associated disability and mortality.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Important considerations at screening

A
  1. Ethical (Harms vs Benefits)

− Subject anxiety and/or stigmatization

− Invasive procedure

+ Improved quality of life

+ Effective treatment can be administered

  1. Characteristics of the condition (disease)

The things we screen on should be : Serious for the individual and the community; Sufficient prevalence in the population

  1. Characteristics of the screening test
  • Reliability and validity (accuracy)
  • Feasibility (burden, cost)
  • Effective (screening reduces severity, mortality)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Test reliability: what? How? Types? Measures?

A
  1. Ability of a measuring instrument to give consistent results on repeated trials (precision)
  2. Established by repeated measurements
  3. Technical reliability (measurement, instrument); Intra- and Inter-examiner reliability
  4. Intraclass correlation coefficient (RIC); Kappa coefficient (k)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Test validity: what? How? Measures?

A
  • Ability of the measuring instrument to give a true measure of the phenomenon being measured (accuracy)

True measure = ‘gold standard’/criterion measure

  • Established by comparison with a “gold standard” measurement or established diagnosis criteria determined by biopsy, surgery, autopsy, etc.

We calculate the degree to which the measure is free of error.

  • Two measures: sensitivity (Se), specificity (Sp)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Measures of test validity: sensitivity (Se), specificity (Sp)

Work on the colums

Both in Percentage

A

Sensitivity: proportion of those with disease testing positive on screening. Se = TP / (TP+FN) = A/A+C
Specificity: proportion of those without disease testing negative on screening. Sp= TN / (TN+FP) = D/B+D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Measures of case yield (predictive values): Positive (PV+), Negative (PV-)

Work on rows

In percentage

A

Positive predictive (PV+): the proportion of individuals screening positive who actually have disease.

PV+ = TP / (TP+FP) = A/A+B

Negative predictive (PV-): the proportion of individuals screening negative who actually do not have disease.

PV- = TN / (TN+FN) = D/C+D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Relationship between measures of validity and case yield

A

If there are a lot of false negative (FN or C), may have low sensitivity (Se), and PV- may be high.

If there are a lot of false positive (FP or B), may have low specificity (Sp), and PV+ may be low.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Interpretations of Se, Sp, PV+, PV-

A

Se: xx% of those who actually have the conditions/disease, we screened for positive.

Sp: xx% of those who don’t have the conditions/disease, we screened for negative.

PV+: xx% of those positive screens are true positive. This is low because there are a lot of false positive (B).

PV-: xx% of those negative screens are true negative This is low because there are a lot of false negative (C).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cut-point Selection for Continuous Factors

A
  • Lower cut-point – more screen positive:

FN lower; FP higher

Se enhanced; Sp reduced

We lower cut-point when:

  1. Identifying every case is necessary (HIV; PKU)
  2. Early treatment is important (breast cancer)
  3. Costs for additional tests is low
  • Higher cut-point – more screen negative

FP lower; FN higher

Sp enhanced; Se reduced

We higher cut-point when:

  1. Costs & risks of re-screening high (colorectal cancer)
  2. Low false positive is desired (gallbladder disease)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How to enhance Se and Sp?

A

Use multiple tests!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is Simultaneous testing (parallel testing) and how to define positive/negative

A

Complete multiple different tests

Screen positive = either test positive

Screen negative = all tests negative

Tends to enhance Se by lower FN (results in lower Sp)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is Sequential testing (serial testing) and how to define positive/negative

A

Positives on test #1 proceed to test #2 (more expensive)

Screen positive = all tests positive

Screen negative = either test negative

Tends to enhance Sp by lower FP (results in lower Se)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is ultimately the most important aspect when evaluating screening programs

A

Effectiveness.

Does screening reduce morbidity & mortality?

  • decrease severity of disease at diagnosis?
  • decrease mortality (deaths)?
17
Q

Three bias of screening

A
  1. selection
  2. lead time
  3. length
18
Q

T/F: validity is measured by sensitivity, specificity, PV+, PV-

A

True

19
Q

T/F: Screening tests must be both reliable and valid.

A

True

20
Q

T/F: Screening program only need to be effective.

A

False. It must be effective and ethical too!